Skip to main content
Neogen Chemicals Limited logo

Neogen Chemicals Limited — Investor Relations & Filings

Ticker · NEOGEN ISIN · INE136S01016 LEI · 335800PFY9B77Z2GOK22 BSE.NS Manufacturing
Open in API
Filings indexed 707 across all filing types
Latest filing 2024-08-07 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS NEOGEN

About Neogen Chemicals Limited

https://neogenchem.com/

Neogen Chemicals Limited specializes in the development and large-scale manufacturing of bromine-based and lithium-based specialty chemicals. The product portfolio includes a diverse range of bromine derivatives, lithium salts, Grignard reagents, and advanced intermediates. These products serve critical roles in pharmaceutical, agrochemical, and engineering applications. The company has expanded its operations into the energy storage market, focusing on the production of electrolytes and lithium salts for lithium-ion batteries. With a strong emphasis on research and development, the firm provides custom synthesis and contract manufacturing services to global innovators. Manufacturing capabilities are supported by multi-product facilities designed to meet stringent quality standards for complex chemical processes and high-purity requirements.

Recent filings

Filing Released Lang Actions
Outcome of Board Meeting
Interim / Quarterly Report Classification · 95% confidence The document is a detailed announcement from Neogen Chemicals Limited dated August 7, 2024, reporting the outcome of a Board Meeting. It includes approval of unaudited standalone and consolidated financial results for the quarter ended June 30, 2024, along with a Limited Review Report by the statutory auditors. It also covers approval of Directors' Report, Management Discussion and Analysis, Business Responsibility and Sustainability Report, Corporate Governance Report for the financial year 2023-24, and notice of the 35th Annual General Meeting. Additionally, it announces appointments and reappointments of directors, committee reconstitutions, and other corporate governance matters. The document contains substantive financial data (unaudited quarterly results) and management and governance information. It is not merely an announcement of a report but includes actual financial results and related reports. Therefore, it fits the definition of an Interim / Quarterly Report (IR) because it contains unaudited quarterly financial results and related disclosures for the quarter ended June 30, 2024, which is a period shorter than a full fiscal year. The presence of the Limited Review Report supports this classification. The document is not a full Annual Report (10-K), nor is it just a Regulatory Filing or Report Publication Announcement. Hence, the best classification is IR with high confidence.
2024-08-07 English
Updates
Regulatory Filings Classification · 95% confidence The document is an official announcement from Neogen Chemicals Limited dated August 3, 2024, addressed to stock exchanges in India. It provides detailed information about the incorporation of a wholly owned subsidiary, Neogen Chemicals Japan Co., Ltd., including share capital, ownership percentage, business purpose, and regulatory references to SEBI Listing Obligations and Disclosure Requirements. The content focuses on corporate structural changes and regulatory compliance disclosures rather than financial results, management changes, or shareholder voting outcomes. It is not a financial report, earnings release, or management discussion. The document is a regulatory announcement about a corporate event (subsidiary incorporation) pursuant to SEBI regulations, fitting the category of a Regulatory Filing (RNS). The document length (6616 characters) and detailed disclosure support this classification rather than a brief report publication announcement or other categories.
2024-08-03 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is an official communication from Neogen Chemicals Limited dated August 1, 2024, addressed to stock exchanges in India. It announces the schedule of an earnings conference call to discuss the Q1 FY25 financial results, specifying the date and time of the call and providing dial-in details. The document explicitly states that the call is for analysts and investors to discuss quarterly results and includes an invitation to the earnings conference call. There is no actual financial data or detailed financial analysis in the document; it is purely an announcement of the upcoming earnings call event. According to the classification rules, such announcements about earnings calls are classified as Call Transcript (CT) only if they contain the full transcript. Since this document is only an announcement of the call schedule and invitation, it is best classified as a Regulatory Filing (RNS) because it is a regulatory announcement under SEBI Listing Regulations about the earnings call schedule. The document length is 15,000 characters, but it does not contain the transcript or financial results themselves, only the notice of the call. Therefore, the correct classification is Regulatory Filings (RNS) with high confidence.
2024-08-01 English
Board Meeting — NEOGEN CHEMICALS LIMITED has informed the Exchange about Board Meeting to be held on 07-Aug-2024 to inter-alia consider and approve the Unaudited Financial results of the Company for…
Regulatory Filings
2024-08-01 English
Board Meeting — Financial Results
Regulatory Filings Classification · 95% confidence The document is a notice of an upcoming Board Meeting scheduled for August 7, 2024, to consider and approve the unaudited financial results for the quarter ended June 30, 2024. It is an intimation pursuant to SEBI Listing Regulations about the meeting date and trading window closure. The document does not contain the financial results themselves, nor detailed financial data or analysis. It is a short notice informing the stock exchanges and public about the board meeting and related compliance matters. Therefore, it is not an Interim/Quarterly Report (IR) or Earnings Release (ER), but rather a regulatory announcement about the board meeting. This fits best under Regulatory Filings (RNS) as a general regulatory announcement and compliance notice.
2024-08-01 English
Credit Rating
Capital/Financing Update Classification · 95% confidence The document is an official communication dated July 8, 2024, addressed to stock exchanges (BSE and NSE) regarding the intimation of credit rating. It references SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, indicating a regulatory compliance announcement. The content details the reaffirmation of credit ratings by CRISIL for various bank facilities of the company. The document is short (3043 characters) and serves as an announcement of the credit rating status rather than a detailed financial report or audit. It does not contain financial statements or management discussion but is an update on the company's credit rating status, which relates to financing activities. Therefore, the most appropriate classification is Capital/Financing Update (CAP).
2024-07-08 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.